With two COVID-19 vaccines now in the final stages of approval for use in the U.S., 63% of Americans say they are willing to be immunized against the disease. The public’s willingness to receive a COVID-19 vaccination approved by the Food and Drug Administration (FDA) has nearly rebounded to the […] Read more »
Intent to Get a COVID-19 Vaccine Rises to 60% as Confidence in Research and Development Process Increases
As vaccines for the coronavirus enter review for emergency use by the U.S. Food and Drug Administration, the share of Americans who say they plan to get vaccinated has increased as the public has grown more confident that the development process will deliver a safe and effective vaccine. Still, the […] Read more »
Coronavirus Vaccine Hesitancy in Black and Latinx Communities
COVID Collaborative, Langer Research, UnidosUS and the NAACP conducted a poll on attitudes and impacts of COVID-19 vaccine hesitancy and resistance in the Black and Latinx communities. The report summarizes these findings and highlights key areas of focus for policy makers, health care professionals, and others working to increase vaccine […] Read more »
Why coronavirus vaccine polling numbers are mostly good news
… There’s been mostly good news on the coronavirus vaccine front. Two separate vaccine makers (Moderna and Pfizer) say their vaccines are about 95% effective with no major safety concerns, and Pfizer has applied to the Food and Drug Administration for emergency authorization. The hope is that many people can […] Read more »
More Americans Now Willing to Get COVID-19 Vaccine
Americans’ willingness to be vaccinated against COVID-19 rebounded a bit in October, as seen in Gallup polling conducted before Pfizer/BioNTech and Moderna made promising announcements about the likely effectiveness of their coronavirus vaccines. Fifty-eight percent of Americans in the latest poll say they would get a COVID-19 vaccine, up from […] Read more »
Next Stop: Georgia
On this week’s episode of Poll Hub, the composition of the U.S. government literally hangs in the balance with two U.S. Senate race runoffs in Georgia serving as arbiters. As time elapses from Election Day to January, what are the challenges for both parties? Then, Pfizer’s announcement of a potentially […] Read more »